Exact Mass: 349.1022

Exact Mass Matches: 349.1022

Found 109 metabolites which its exact mass value is equals to given mass value 349.1022, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ampicillin

(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID

C16H19N3O4S (349.1096)


Ampicillin is found in common pea. It is also a potential contaminant of cows milk arising from its veterinary use. Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. It has been used extensively to treat bacterial infections since 1961. It is considered part of the aminopenicillin family and is roughly equivalent to amoxicillin in terms of spectrum and level of activity J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic KEIO_ID A197

   

10-Hydroxydihydrosanguinarine

10-Hydroxydihydrosanguinarine

C20H15NO5 (349.095)


A benzophenanthridine alkaloid comprising dihydrosanguinarine carrying a hydroxy substituent at the 10-position.

   

Cefradine

(6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H19N3O4S (349.1096)


Cefradine is only found in individuals that have used or taken this drug. It is a semi-synthetic cephalosporin antibiotic.Cefradine is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Cefradine interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Penicillin T

(p-Aminobenzyl)penicillin; Penicillin T

C16H19N3O4S (349.1096)


   

S-(Formylmethyl)glutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-oxoethyl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C12H19N3O7S (349.0944)


This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.

   

4-(3'-Di(2-chloroethyl)aminopropionyl)biphenyl

1-{[1,1-biphenyl]-4-yl}-3-[bis(2-chloroethyl)amino]propan-1-one

C19H21Cl2NO (349.1)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds

   

6-[(2S,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]oxane-2,5-dione

6-[(2S,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]oxane-2,5-dione

C14H15N5O6 (349.1022)


   

Neoamphimedine Y

Neoamphimedine Y

C19H15N3O4 (349.1063)


   

S-(Formylmethyl)glutathione

S-(Formylmethyl)glutathione

C12H19N3O7S (349.0944)


   
   
   

Metazachlor-sulfinyl-acetic acid BH 479-9

Metazachlor-sulfinyl-acetic acid BH 479-9

C16H19N3O4S (349.1096)


   

N-Acetyldemethylphosphinothricin tripeptide

N-Acetyldemethylphosphinothricin tripeptide

C12H20N3O7P (349.1039)


   

8-Methoxyisodecarine

8-Methoxyisodecarine

C20H15NO5 (349.095)


   

1-Methoxy-2-hydroxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-13(12H)-one

1-Methoxy-2-hydroxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-13(12H)-one

C20H15NO5 (349.095)


   

9-O-acetyl-2-deoxy-N-glycoloyl-2,3-didehydroneuraminic acid

9-O-acetyl-2-deoxy-N-glycoloyl-2,3-didehydroneuraminic acid

C13H19NO10 (349.1009)


   

sanguinarin

sanguinarin

C20H15NO5 (349.095)


   

2-hydroxy-3-methoxy-12-methyl-12h-[1,3]dioxolo [4,5:4,5]benzo[1,2-c]-phenanthridin-13-one

2-hydroxy-3-methoxy-12-methyl-12h-[1,3]dioxolo [4,5:4,5]benzo[1,2-c]-phenanthridin-13-one

C20H15NO5 (349.095)


   

8-Hydroxydihydrosanguinarine

8-Hydroxydihydrosanguinarine

C20H15NO5 (349.095)


   

N,O-diacetylaristololactam A-II

N,O-diacetylaristololactam A-II

C20H15NO5 (349.095)


   
   
   
   
   
   
   
   

Norisoboldine hydrochloride

4H-Dibenzo[de,g]quinoline-1,9-diol, 5,6,6a,7-tetrahydro-2,10-dimethoxy-, hydrochloride, (S)-

C18H20ClNO4 (349.1081)


   

Laurolitsine hydrochloride

(6aS)-1,10-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol;hydrochloride

C18H20ClNO4 (349.1081)


   

Ampicillin

Ampicillin

C16H19N3O4S (349.1096)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic relative retention time with respect to 9-anthracene Carboxylic Acid is 0.412 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.411 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3661 EAWAG_UCHEM_ID 3661; CONFIDENCE standard compound

   
   
   

Metazachlor BH 479-9

Metazachlor BH 479-9

C16H19N3O4S (349.1096)


CONFIDENCE standard compound; INTERNAL_ID 2649

   

Cys Gly Gly Asn

(2S)-2-(2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C11H19N5O6S (349.1056)


   

Cys Gly Asn Gly

2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]acetic acid

C11H19N5O6S (349.1056)


   

Cys Asn Gly Gly

2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}acetic acid

C11H19N5O6S (349.1056)


   

Gly Cys Gly Asn

(2S)-2-{2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

C11H19N5O6S (349.1056)


   

Gly Cys Asn Gly

2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetic acid

C11H19N5O6S (349.1056)


   

Gly Gly Cys Asn

(2S)-2-[(2R)-2-[2-(2-aminoacetamido)acetamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C11H19N5O6S (349.1056)


   

Gly Gly Asn Cys

(2R)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C11H19N5O6S (349.1056)


   

Gly Asn Cys Gly

2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetic acid

C11H19N5O6S (349.1056)


   

Gly Asn Gly Cys

(2R)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoic acid

C11H19N5O6S (349.1056)


   
   
   
   

Asn Cys Gly Gly

2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}acetic acid

C11H19N5O6S (349.1056)


   

Asn Gly Cys Gly

2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]acetic acid

C11H19N5O6S (349.1056)


   

Asn Gly Gly Cys

(2R)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-3-sulfanylpropanoic acid

C11H19N5O6S (349.1056)


   
   
   

Ethosuximide M3 glucuronide

Ethosuximide M3 glucuronide

C13H19NO10 (349.1009)


   

(-)-(1R,2S)-N-benzyl-N-methylephedrinium bromide

(-)-(1R,2S)-N-benzyl-N-methylephedrinium bromide

C18H24BrNO (349.1041)


   

N7-(4-METHOXYPHENYL)-N2-PHENYLTHIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE

N7-(4-METHOXYPHENYL)-N2-PHENYLTHIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE

C18H15N5OS (349.0997)


   

6-amino-2-chloropurine

6-amino-2-chloropurine

C19H16ClN5 (349.1094)


   

HL-Asp(Bzl)-OBzl * HCl

HL-Asp(Bzl)-OBzl * HCl

C18H20ClNO4 (349.1081)


   

H-D-Asp(Obzl)-Obzl.HCl

H-D-Asp(Obzl)-Obzl.HCl

C18H20ClNO4 (349.1081)


   

Resminostat

Resminostat

C16H19N3O4S (349.1096)


C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

S-Acetylglutathione

γ-Glutamyl-S-acetylcysteinylglycine

C12H19N3O7S (349.0944)


   

benzyl N-(3-cyano-6-methoxy-4-oxo-1H-quinolin-7-yl)carbamate

benzyl N-(3-cyano-6-methoxy-4-oxo-1H-quinolin-7-yl)carbamate

C19H15N3O4 (349.1063)


   

(S)-2-BENZYL-3-(BENZYLOXY)-3-OXOPROPANE-1-SULFONIC ACID

(S)-2-BENZYL-3-(BENZYLOXY)-3-OXOPROPANE-1-SULFONIC ACID

C17H19NO5S (349.0984)


   

ETHYL 5-HYDROXY-7-OXO-2-PHENYL-8-(PROP-2-YNYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

ETHYL 5-HYDROXY-7-OXO-2-PHENYL-8-(PROP-2-YNYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C19H15N3O4 (349.1063)


   

Dimethachlor Metabolite SYN 528702 sodium salt

Dimethachlor Metabolite SYN 528702 sodium salt

C15H20NNaO5S (349.096)


   

3-(4-Ethoxy-3-methoxy-phenyl)-3-[(thiophene-2-carbonyl)-amino]-propionic acid

3-(4-Ethoxy-3-methoxy-phenyl)-3-[(thiophene-2-carbonyl)-amino]-propionic acid

C17H19NO5S (349.0984)


   

1-(4-Propylphenyl)-2,5-di(2-thienyl)-1H-pyrrole

1-(4-Propylphenyl)-2,5-di(2-thienyl)-1H-pyrrole

C21H19NS2 (349.0959)


   

2-(4-Dibenzothiophene)carbazole

2-(4-Dibenzothiophene)carbazole

C24H15NS (349.0925)


   

3-{[(4-Methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate

3-{[(4-Methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate

C16H19N3O4S (349.1096)


   

Ecopipam hydrochloride

Ecopipam hydrochloride

C19H21Cl2NO (349.1)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Ecopipam (SCH 39166) hydrochloride is a potent, selective and orally active antagonist of dopamine D1/D5 receptor, with Kis of 1.2 nM and 2.0 nM, respectively. Ecopipam hydrochloride shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a receptor (Ki=0.98, 5.52, 0.08, and 0.73 μM, respectively). Ecopipam hydrochloride can be used for the research of schizophrenia and obesity[1][3].

   

2-[[2-(3-Methyl-2-methylimino-4-oxo-5-thiazolidinyl)-1-oxoethyl]amino]benzoic acid ethyl ester

2-[[2-(3-Methyl-2-methylimino-4-oxo-5-thiazolidinyl)-1-oxoethyl]amino]benzoic acid ethyl ester

C16H19N3O4S (349.1096)


   

(E)-N-(furan-2-ylmethyl)-2-(3,4,5-trimethoxybenzylidene)hydrazinecarbothioamide

(E)-N-(furan-2-ylmethyl)-2-(3,4,5-trimethoxybenzylidene)hydrazinecarbothioamide

C16H19N3O4S (349.1096)


   

2-[[5-(4-Ethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-morpholinyl)ethanone

2-[[5-(4-Ethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-morpholinyl)ethanone

C16H19N3O4S (349.1096)


   

Chromophore (Met-Tyr-Gly)

Chromophore (Met-Tyr-Gly)

C16H19N3O4S (349.1096)


   
   

3-(2-chlorophenyl)-2,5-dimethyl-N-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine

3-(2-chlorophenyl)-2,5-dimethyl-N-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine

C19H16ClN5 (349.1094)


   

estrone 3-sulfate

estrone 3-sulfate

C18H21O5S- (349.111)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

(6R,7R)-7-[[(2R)-2-azaniumyl-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7R)-7-[[(2R)-2-azaniumyl-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C16H19N3O4S (349.1096)


   

(2S,5R,6R)-6-[[(2R)-2-azaniumyl-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

(2S,5R,6R)-6-[[(2R)-2-azaniumyl-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C16H19N3O4S (349.1096)


   

[(3S)-3-acetamido-4-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutyl]-oxido-oxophosphanium

[(3S)-3-acetamido-4-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutyl]-oxido-oxophosphanium

C12H20N3O7P (349.1039)


   

6-[(2S,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]oxane-2,5-dione

6-[(2S,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]oxane-2,5-dione

C14H15N5O6 (349.1022)


   

N,N-dimethylcarbamic acid [4-[6-(trifluoromethyl)-2-imidazo[1,2-a]pyridinyl]phenyl] ester

N,N-dimethylcarbamic acid [4-[6-(trifluoromethyl)-2-imidazo[1,2-a]pyridinyl]phenyl] ester

C17H14F3N3O2 (349.1038)


   

N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-7-nitro-1H-benzimidazole-4-carboxamide

N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-7-nitro-1H-benzimidazole-4-carboxamide

C15H16ClN5O3 (349.0942)


   

N-{(E)-[5-(4-nitrophenyl)furan-2-yl]methylidene}-2-phenylacetohydrazide

N-{(E)-[5-(4-nitrophenyl)furan-2-yl]methylidene}-2-phenylacetohydrazide

C19H15N3O4 (349.1063)


   

6-(2-chlorophenyl)-N-(2-furanylmethyl)-N-methyl-4-quinazolinamine

6-(2-chlorophenyl)-N-(2-furanylmethyl)-N-methyl-4-quinazolinamine

C20H16ClN3O (349.0982)


   

N-naphthalen-2-yl-2-[(E)-(3-nitrophenyl)methylideneamino]oxyacetamide

N-naphthalen-2-yl-2-[(E)-(3-nitrophenyl)methylideneamino]oxyacetamide

C19H15N3O4 (349.1063)


   
   
   
   
   
   
   
   
   
   
   
   
   

Cefradine

Cephradine

C16H19N3O4S (349.1096)


A cephalosporin with a methyl substituent at position 3, and a (2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetamido substituent at position 7, of the cephem skeleton. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

estrone 3-sulfate(1-)

estrone 3-sulfate(1-)

C18H21O5S (349.111)


The conjugate base of estrone 3-sulfate; major species at pH 7.3.

   

Hydroxydihydrosanguinarine

Hydroxydihydrosanguinarine

C20H15NO5 (349.095)


   

Laurolitsine (hydrochloride)

Laurolitsine (hydrochloride)

C18H20ClNO4 (349.1081)


Laurolitsine hydrochloride is an alkaloid isolated from Phoebe formosana, and shows weak anti-inflammatory activity.

   

Laurolitsine (hydrochloride)

Laurolitsine (hydrochloride)

C18H20ClNO4 (349.1081)


Laurolitsine hydrochloride is an alkaloid isolated from Phoebe formosana, and shows weak anti-inflammatory activity.

   

17,20-dimethoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaen-18-ol

17,20-dimethoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaen-18-ol

C20H15NO5 (349.095)


   

(3r,4r)-3,4,8-trihydroxy-5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,7,9,11,13(21),14,16,18-octaen-6-one

(3r,4r)-3,4,8-trihydroxy-5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,7,9,11,13(21),14,16,18-octaen-6-one

C19H15N3O4 (349.1063)


   

(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

C20H15NO5 (349.095)


   

17-hydroxy-16-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

17-hydroxy-16-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

C20H15NO5 (349.095)


   

10-acetyl-15-methoxy-11-oxo-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-14-yl acetate

10-acetyl-15-methoxy-11-oxo-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-14-yl acetate

C20H15NO5 (349.095)


   

(2s,5r,6r)-6-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2s,5r,6r)-6-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H19N3O4S (349.1096)


   

17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

C20H15NO5 (349.095)


   

24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-ol

C20H15NO5 (349.095)